New Year, New You: Walmart Launches Better Care Services and Rolls Back Prices on 1,000+ Wellness Essentials

BENTONVILLE, Ark.–(BUSINESS WIRE)–Walmart is starting the new year by making healthcare easier and more affordable with the launch of Better Care Services. This one-stop digital destination is designed to help empower millions of customers to take control of their health journeys with ease, transparency and confidence. “We know that when heath care feels hard, many … [Read more…]

During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media

Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of the Media, and 1,200+ Investors Registration and Partnering Platform Access Now Open SAN FRANCISCO–(BUSINESS WIRE)–#biotechshowcase–More than 3,000 leaders within biotechnology are registered to attend Biotech Showcase 2026 during J.P. Morgan Healthcare Week for unmatched opportunity to forge … [Read more…]

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS

~ Designation enables an enhanced development path for VTx-002 and underscores its disease-modifying potential in ALS, a universally fatal disease with no cure ~ ~ Milestone follows recent IND clearance and supports continued advancement of VTx-002 toward the planned PIONEER-ALS Phase 1/2 clinical study ~ AMSTERDAM & BOSTON–(BUSINESS WIRE)–VectorY Therapeutics, a leader in vectorized antibody … [Read more…]

FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference

PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over … [Read more…]

Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference

LEIDEN, Netherlands–(BUSINESS WIRE)–#Adults—Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare Conference on Thursday, January 15. The company’s presentation will begin at 9:30 am PT/12:30 am ET/6:30 am CET. The presentation … [Read more…]

Novotech Appoints Anand Tharmaratnam as New CEO

SINGAPORE–(BUSINESS WIRE)–#ClinicalTrials–Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. Tharmaratnam brings nearly three decades of experience in the global CRO industry and has served as Novotech Chairman since 2021. He commenced as Chairman and CEO on … [Read more…]

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time. A live audio webcast of the presentation will be available on the … [Read more…]

InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform

InduPro will leverage its proprietary platform to develop bi- and tri-specific therapeutics that discover rationally selected Tumor Associated Proximity Antigens (TAPAs) to pair as co-targets with Tumor Associated Antigens, in collaboration with Lilly SEATTLE & CAMBRIDGE, Mass.–(BUSINESS WIRE)–InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of … [Read more…]

Lumicera Health Services Promotes Ben Heiser to Senior Vice President and CEO During Period of Historic Growth

Service expansions accelerate pharmacy’s achievement of 2 million shipments while maintaining industry-leading patient support MADISON, Wis.–(BUSINESS WIRE)–Lumicera Health Services, a leading specialty pharmacy solutions provider and Top 10 national specialty pharmacy, announced today the promotion of Ben Heiser, PharmD, to Senior Vice President and Chief Executive Officer (CEO). ​This follows a period of sustained expansion … [Read more…]

Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Stylus Medicine, Inc. (“Stylus”), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT. About Stylus Medicine Stylus Medicine is developing transformative … [Read more…]